Preimplantation Genetic Diagnosis
and Screening at The Bridge Centre		  
PGD-PGS
   

Site updated: 30th July 2008

Focus on genetics

Preimplantation genetic screening (PGS) for aneuploidy (abnormal chromosome number) is available to women of advanced maternal age (35 years and above) with a history of IVF failure and/or recurrent miscarriage and other at risk couples. Follow-up analysis of abnormal embryos also provides valuable information about your chance of a live birth.

Currently we offer PGS for 7 chromosomes (out of 24 in total) frequently found in early embryos which result in miscarriage or abnormality. We will soon be expanding the number of chromosomes analysed and are developing new methods for 24 chromosome screening.

Professor Alan Handyside

Professor Alan H Handyside MA PhD
Scientific Director

Pioneered Preimplantation Genetic Diagnosis (PGD) with Professor Lord Robert Winston at Hammersmith Hospital, London in the late eighties. Co-founder and first Chairman of the European Society for Human Reproduction and Embryology PGD Consortium. Professor of Developmental Biology, School of Biology, University of Leeds.

Bridge has been running a preimplantation genetic diagnosis and screening (PGD-PGS) programme since January 2004. Two years in the planning and licensed by the Human Fertilisation and Embryology Authority (HFEA), this is one of the most comprehensive services available anywhere in Europe and is directed by Professor Alan Handyside, Director of Bridge and Dr Alan Thornhill, Scientific Director of Bridge.

For further information on PGD or PGS at Bridge click on the following links or contact Charlotte Bancroft on 020 7403 3363 to arrange a consultation.

Preimplantation Genetic Diagnosis (PGD) - under reconstruction

Preimplantation Genetic Screening (PGS) - under reconstruction

Useful Links | © 2008